These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 15170907)
1. Is there a rationale for switching from one anti-tumor necrosis factor agent to another? Haraoui B J Rheumatol; 2004 Jun; 31(6):1021-2. PubMed ID: 15170907 [No Abstract] [Full Text] [Related]
2. Anti-tumour necrosis factor agents and lipid profile: a class effect? Garcês SP; Parreira Santos MJ; Vinagre FM; Roque RM; da Silva JA Ann Rheum Dis; 2008 Jun; 67(6):895-6. PubMed ID: 18474660 [No Abstract] [Full Text] [Related]
3. Introduction to special section: biologic agents in the treatment of rheumatic diseases-the first decade. Yelin E; Katz P Arthritis Rheum; 2009 May; 61(5):559. PubMed ID: 19405010 [No Abstract] [Full Text] [Related]